WESTBOROUGH, Mass., Feb. 25 /PRNewswire/ -- "The Inaugural BioProcess International Conference & Exhibition continues IBC's legacy of delivering superior programming for the bioprocessing industry," says Jim Wagner, Global Director, IBC Life Sciences. "This is the largest most influential bioprocessing event to take place in the fall of 2004, delivering the tools and knowledge the biopharmaceutical industry needs to accelerate its programs -- comprehensive updates on operational strategies, technologies, regulatory changes, manufacturing production and process development."
EVENT: IBC's Inaugural BioProcess International Conference & Exhibition DATE: October 4-8, 2004 LOCATION: The New Boston Convention & Exhibition Center, Boston, MA WHO SHOULD ATTEND: Senior scientists, scientists, executives and managers who work for major biopharm companies or small firms preparing to manufacture a biotherapeutic for the first time. FEATURING: Over 500 participants and 40 exhibitors bound by the common goal of optimizing manufacturing processes DETAILS: http://www.lifesciencesinfo.com/BPI?source=3070pr1
A scientific advisory board has been formed and is actively recruiting biopharm thought leaders who will address topics ranging from high level strategic planning to the nuts and bolts of scale-up, upstream and downstream process optimization and cutting-edge technologies.
The resulting comprehensive program will consist of four in-depth "FlexTrack" modules that allow attendees the freedom to mix-and-match sessions to design a program tailored to their specific information needs:
1. Production & Economics 2. Scaling Up from Bench to Clinic 3. Cell Culture, Fermentation & Upstream Processing 4. Recovery, Purification & Downstream Processing
Plus, a Regulatory Report session will cover regulatory updates, comparability, immunogenicity, disposables and process analytical technologies.
"Hands-down, IBC conferences are an excellent forum for networking and best-practice sharing. Gain strategic insight into the issues and challenges currently facing the industry. Learn how other companies are addressing these issues and what technologies and strategies they are applying." -- William Taylor, Strategic External Alliances Leader, Pfizer Global R&D, Pharmaceutical Sciences -- Global Biologicals
EDITORS:
We invite you to include this event in your calendar listings. Press passes are available. Please contact Anna Allen at aallen@ibcusa.com or +1 (508) 614-1430.
IBCCONTACT: Anna Allen of IBC, +1-508-614-1430, anna_allen@ibcusa.com
Web site: http://www.lifesciencesinfo.com/
